id	sid	tid	token	lemma	pos
dhrp-28	1	1	2021	2021	NUM
dhrp-28	1	2	,	,	PUNCT
dhrp-28	1	3	vol	vol	NOUN
dhrp-28	1	4	.	.	NOUN
dhrp-28	1	5	1	1	NUM
dhrp-28	1	6	(	(	PUNCT
dhrp-28	1	7	s4	s4	PROPN
dhrp-28	1	8	)	)	PUNCT
dhrp-28	1	9	17	17	NUM
dhrp-28	1	10	-	-	SYM
dhrp-28	1	11	19	19	NUM
dhrp-28	1	12	https://doi.org/10.47488/dhrp.v1is4.28	https://doi.org/10.47488/dhrp.v1is4.28	NOUN
dhrp-28	1	13	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-28	1	14	17	17	NUM
dhrp-28	1	15	©	©	PROPN
dhrp-28	1	16	dhr	dhr	PROPN
dhrp-28	1	17	health	health	PROPN
dhrp-28	1	18	institute	institute	PROPN
dhrp-28	1	19	for	for	ADP
dhrp-28	1	20	research	research	NOUN
dhrp-28	1	21	and	and	CCONJ
dhrp-28	1	22	development	development	NOUN
dhrp-28	1	23	editorial	editorial	NOUN
dhrp-28	1	24	insufficient	insufficient	ADJ
dhrp-28	1	25	scientific	scientific	ADJ
dhrp-28	1	26	evidence	evidence	NOUN
dhrp-28	1	27	supporting	support	VERB
dhrp-28	1	28	the	the	DET
dhrp-28	1	29	use	use	NOUN
dhrp-28	1	30	of	of	ADP
dhrp-28	1	31	ivermectin	ivermectin	NOUN
dhrp-28	1	32	in	in	ADP
dhrp-28	1	33	the	the	DET
dhrp-28	1	34	prevention	prevention	NOUN
dhrp-28	1	35	and	and	CCONJ
dhrp-28	1	36	treatment	treatment	NOUN
dhrp-28	1	37	of	of	ADP
dhrp-28	1	38	covid-19	covid-19	PROPN
dhrp-28	1	39	ivermectin	ivermectin	NOUN
dhrp-28	1	40	–	–	PUNCT
dhrp-28	1	41	a	a	DET
dhrp-28	1	42	drug	drug	NOUN
dhrp-28	1	43	obtained	obtain	VERB
dhrp-28	1	44	following	follow	VERB
dhrp-28	1	45	fermentation	fermentation	NOUN
dhrp-28	1	46	of	of	ADP
dhrp-28	1	47	streptomyces	streptomyce	NOUN
dhrp-28	1	48	avermitilis	avermitili	NOUN
dhrp-28	1	49	,	,	PUNCT
dhrp-28	1	50	was	be	AUX
dhrp-28	1	51	discovered	discover	VERB
dhrp-28	1	52	in	in	ADP
dhrp-28	1	53	1975	1975	NUM
dhrp-28	1	54	and	and	CCONJ
dhrp-28	1	55	was	be	AUX
dhrp-28	1	56	approved	approve	VERB
dhrp-28	1	57	for	for	ADP
dhrp-28	1	58	medical	medical	ADJ
dhrp-28	1	59	use	use	NOUN
dhrp-28	1	60	in	in	ADP
dhrp-28	1	61	1981	1981	NUM
dhrp-28	1	62	.	.	PUNCT
dhrp-28	2	1	its	its	PRON
dhrp-28	2	2	discovery	discovery	NOUN
dhrp-28	2	3	was	be	AUX
dhrp-28	2	4	hailed	hail	VERB
dhrp-28	2	5	as	as	ADP
dhrp-28	2	6	an	an	DET
dhrp-28	2	7	innovation	innovation	NOUN
dhrp-28	2	8	in	in	ADP
dhrp-28	2	9	medicine	medicine	NOUN
dhrp-28	2	10	resulting	result	VERB
dhrp-28	2	11	in	in	ADP
dhrp-28	2	12	the	the	DET
dhrp-28	2	13	conferring	conferring	NOUN
dhrp-28	2	14	of	of	ADP
dhrp-28	2	15	the	the	DET
dhrp-28	2	16	2015	2015	NUM
dhrp-28	2	17	nobel	nobel	PROPN
dhrp-28	2	18	prize	prize	PROPN
dhrp-28	2	19	in	in	ADP
dhrp-28	2	20	physiology	physiology	NOUN
dhrp-28	2	21	or	or	CCONJ
dhrp-28	2	22	medicine	medicine	NOUN
dhrp-28	2	23	to	to	ADP
dhrp-28	2	24	william	william	PROPN
dhrp-28	2	25	campbell	campbell	PROPN
dhrp-28	2	26	and	and	CCONJ
dhrp-28	2	27	satoshi	satoshi	PROPN
dhrp-28	2	28	ōmura	ōmura	PROPN
dhrp-28	2	29	for	for	ADP
dhrp-28	2	30	its	its	PRON
dhrp-28	2	31	discovery	discovery	NOUN
dhrp-28	2	32	and	and	CCONJ
dhrp-28	2	33	applications	application	NOUN
dhrp-28	2	34	.	.	PUNCT
dhrp-28	3	1	in	in	ADP
dhrp-28	3	2	humans	human	NOUN
dhrp-28	3	3	,	,	PUNCT
dhrp-28	3	4	u.s	u.s	PROPN
dhrp-28	3	5	.	.	PROPN
dhrp-28	3	6	food	food	PROPN
dhrp-28	3	7	and	and	CCONJ
dhrp-28	3	8	drug	drug	PROPN
dhrp-28	3	9	administration	administration	PROPN
dhrp-28	3	10	(	(	PUNCT
dhrp-28	3	11	fda	fda	PROPN
dhrp-28	3	12	)	)	PUNCT
dhrp-28	3	13	has	have	AUX
dhrp-28	3	14	approved	approve	VERB
dhrp-28	3	15	ivermectin	ivermectin	NOUN
dhrp-28	3	16	for	for	ADP
dhrp-28	3	17	the	the	DET
dhrp-28	3	18	treatment	treatment	NOUN
dhrp-28	3	19	of	of	ADP
dhrp-28	3	20	parasite	parasite	NOUN
dhrp-28	3	21	infestations	infestation	NOUN
dhrp-28	3	22	which	which	PRON
dhrp-28	3	23	includes	include	VERB
dhrp-28	3	24	head	head	NOUN
dhrp-28	3	25	lice	lice	NOUN
dhrp-28	3	26	,	,	PUNCT
dhrp-28	3	27	scabies	scabie	NOUN
dhrp-28	3	28	,	,	PUNCT
dhrp-28	3	29	river	river	NOUN
dhrp-28	3	30	blindness	blindness	NOUN
dhrp-28	3	31	,	,	PUNCT
dhrp-28	3	32	lymphatic	lymphatic	ADJ
dhrp-28	3	33	filariasis	filariasis	NOUN
dhrp-28	3	34	,	,	PUNCT
dhrp-28	3	35	strongyloidiasis	strongyloidiasis	NOUN
dhrp-28	3	36	,	,	PUNCT
dhrp-28	3	37	trichuriasis	trichuriasis	NOUN
dhrp-28	3	38	and	and	CCONJ
dhrp-28	3	39	ascariasis	ascariasis	NOUN
dhrp-28	3	40	.	.	PUNCT
dhrp-28	4	1	in	in	ADP
dhrp-28	4	2	veterinary	veterinary	ADJ
dhrp-28	4	3	medicine	medicine	NOUN
dhrp-28	4	4	,	,	PUNCT
dhrp-28	4	5	ivermectin	ivermectin	NOUN
dhrp-28	4	6	is	be	AUX
dhrp-28	4	7	used	use	VERB
dhrp-28	4	8	to	to	PART
dhrp-28	4	9	prevent	prevent	VERB
dhrp-28	4	10	and	and	CCONJ
dhrp-28	4	11	treat	treat	VERB
dhrp-28	4	12	heartworm	heartworm	NOUN
dhrp-28	4	13	and	and	CCONJ
dhrp-28	4	14	acariasis	acariasis	NOUN
dhrp-28	4	15	,	,	PUNCT
dhrp-28	4	16	among	among	ADP
dhrp-28	4	17	other	other	ADJ
dhrp-28	4	18	diseases	disease	NOUN
dhrp-28	4	19	.	.	PUNCT
dhrp-28	5	1	the	the	DET
dhrp-28	5	2	anti	anti	ADJ
dhrp-28	5	3	-	-	ADJ
dhrp-28	5	4	parasitic	parasitic	ADJ
dhrp-28	5	5	mode	mode	NOUN
dhrp-28	5	6	of	of	ADP
dhrp-28	5	7	action	action	NOUN
dhrp-28	5	8	of	of	ADP
dhrp-28	5	9	ivermectin	ivermectin	NOUN
dhrp-28	5	10	has	have	AUX
dhrp-28	5	11	been	be	AUX
dhrp-28	5	12	well	well	ADV
dhrp-28	5	13	-	-	PUNCT
dhrp-28	5	14	defined	define	VERB
dhrp-28	5	15	.	.	PUNCT
dhrp-28	6	1	it	it	PRON
dhrp-28	6	2	acts	act	VERB
dhrp-28	6	3	by	by	ADP
dhrp-28	6	4	binding	bind	VERB
dhrp-28	6	5	to	to	ADP
dhrp-28	6	6	the	the	DET
dhrp-28	6	7	gammaaminobutyric	gammaaminobutyric	ADJ
dhrp-28	6	8	acid	acid	NOUN
dhrp-28	6	9	(	(	PUNCT
dhrp-28	6	10	gaba	gaba	NOUN
dhrp-28	6	11	)	)	PUNCT
dhrp-28	6	12	receptors	receptor	NOUN
dhrp-28	6	13	which	which	PRON
dhrp-28	6	14	results	result	VERB
dhrp-28	6	15	in	in	ADP
dhrp-28	6	16	increased	increase	VERB
dhrp-28	6	17	influx	influx	NOUN
dhrp-28	6	18	of	of	ADP
dhrp-28	6	19	chloride	chloride	NOUN
dhrp-28	6	20	ion	ion	NOUN
dhrp-28	6	21	with	with	ADP
dhrp-28	6	22	consequential	consequential	ADJ
dhrp-28	6	23	hyperpolarization	hyperpolarization	NOUN
dhrp-28	6	24	and	and	CCONJ
dhrp-28	6	25	paralysis	paralysis	NOUN
dhrp-28	6	26	.	.	PUNCT
dhrp-28	7	1	on	on	ADP
dhrp-28	7	2	the	the	DET
dhrp-28	7	3	contrary	contrary	NOUN
dhrp-28	7	4	,	,	PUNCT
dhrp-28	7	5	its	its	PRON
dhrp-28	7	6	mode	mode	NOUN
dhrp-28	7	7	of	of	ADP
dhrp-28	7	8	action	action	NOUN
dhrp-28	7	9	in	in	ADP
dhrp-28	7	10	sars	sar	NOUN
dhrp-28	7	11	-	-	PUNCT
dhrp-28	7	12	cov-2	cov-2	PART
dhrp-28	7	13	infection	infection	NOUN
dhrp-28	7	14	is	be	AUX
dhrp-28	7	15	debatable	debatable	ADJ
dhrp-28	7	16	.	.	PUNCT
dhrp-28	8	1	while	while	SCONJ
dhrp-28	8	2	the	the	DET
dhrp-28	8	3	conclusions	conclusion	NOUN
dhrp-28	8	4	of	of	ADP
dhrp-28	8	5	this	this	DET
dhrp-28	8	6	manuscript	manuscript	NOUN
dhrp-28	8	7	are	be	AUX
dhrp-28	8	8	currently	currently	ADV
dhrp-28	8	9	under	under	ADP
dhrp-28	8	10	reconsideration	reconsideration	NOUN
dhrp-28	8	11	and	and	CCONJ
dhrp-28	8	12	are	be	AUX
dhrp-28	8	13	subject	subject	ADJ
dhrp-28	8	14	to	to	ADP
dhrp-28	8	15	serious	serious	ADJ
dhrp-28	8	16	scientific	scientific	ADJ
dhrp-28	8	17	criticism	criticism	NOUN
dhrp-28	8	18	,	,	PUNCT
dhrp-28	8	19	zaidi	zaidi	PROPN
dhrp-28	8	20	and	and	CCONJ
dhrp-28	8	21	dehgani	dehgani	PROPN
dhrp-28	8	22	-	-	PUNCT
dhrp-28	8	23	mobaraki	mobaraki	PROPN
dhrp-28	8	24	have	have	AUX
dhrp-28	8	25	suggested	suggest	VERB
dhrp-28	8	26	that	that	SCONJ
dhrp-28	8	27	in	in	ADP
dhrp-28	8	28	addition	addition	NOUN
dhrp-28	8	29	to	to	ADP
dhrp-28	8	30	inhibiting	inhibit	VERB
dhrp-28	8	31	host	host	NOUN
dhrp-28	8	32	importin	importin	NOUN
dhrp-28	8	33	alpha	alpha	PROPN
dhrp-28	8	34	/	/	SYM
dhrp-28	8	35	beta-1	beta-1	VERB
dhrp-28	8	36	nuclear	nuclear	ADJ
dhrp-28	8	37	transport	transport	NOUN
dhrp-28	8	38	proteins	protein	NOUN
dhrp-28	8	39	,	,	PUNCT
dhrp-28	8	40	which	which	PRON
dhrp-28	8	41	are	be	AUX
dhrp-28	8	42	part	part	NOUN
dhrp-28	8	43	of	of	ADP
dhrp-28	8	44	a	a	DET
dhrp-28	8	45	key	key	ADJ
dhrp-28	8	46	intracellular	intracellular	ADJ
dhrp-28	8	47	transport	transport	NOUN
dhrp-28	8	48	process	process	NOUN
dhrp-28	8	49	that	that	PRON
dhrp-28	8	50	viruses	viruse	VERB
dhrp-28	8	51	hijack	hijack	VERB
dhrp-28	8	52	to	to	PART
dhrp-28	8	53	enhance	enhance	VERB
dhrp-28	8	54	infection	infection	NOUN
dhrp-28	8	55	by	by	ADP
dhrp-28	8	56	suppressing	suppress	VERB
dhrp-28	8	57	the	the	DET
dhrp-28	8	58	host	host	NOUN
dhrp-28	8	59	’s	’s	PART
dhrp-28	8	60	antiviral	antiviral	ADJ
dhrp-28	8	61	response	response	NOUN
dhrp-28	8	62	,	,	PUNCT
dhrp-28	8	63	ivermectin	ivermectin	NOUN
dhrp-28	8	64	also	also	ADV
dhrp-28	8	65	acts	act	VERB
dhrp-28	8	66	by	by	ADP
dhrp-28	8	67	inhibiting	inhibit	VERB
dhrp-28	8	68	the	the	DET
dhrp-28	8	69	binding	binding	NOUN
dhrp-28	8	70	of	of	ADP
dhrp-28	8	71	sars	sar	NOUN
dhrp-28	8	72	-	-	PUNCT
dhrp-28	8	73	cov-2	cov-2	NOUN
dhrp-28	8	74	to	to	ADP
dhrp-28	8	75	ace-2	ace-2	PUNCT
dhrp-28	8	76	receptors	receptor	NOUN
dhrp-28	8	77	(	(	PUNCT
dhrp-28	8	78	1	1	NUM
dhrp-28	8	79	)	)	PUNCT
dhrp-28	8	80	.	.	PUNCT
dhrp-28	9	1	a	a	DET
dhrp-28	9	2	recent	recent	ADJ
dhrp-28	9	3	study	study	NOUN
dhrp-28	9	4	showed	show	VERB
dhrp-28	9	5	ivermectin	ivermectin	NOUN
dhrp-28	9	6	had	have	AUX
dhrp-28	9	7	proven	prove	VERB
dhrp-28	9	8	effective	effective	ADJ
dhrp-28	9	9	as	as	ADP
dhrp-28	9	10	an	an	DET
dhrp-28	9	11	inhibitor	inhibitor	NOUN
dhrp-28	9	12	of	of	ADP
dhrp-28	9	13	covid-19	covid-19	PROPN
dhrp-28	9	14	,	,	PUNCT
dhrp-28	9	15	however	however	ADV
dhrp-28	9	16	the	the	DET
dhrp-28	9	17	experiments	experiment	NOUN
dhrp-28	9	18	conducted	conduct	VERB
dhrp-28	9	19	in	in	ADP
dhrp-28	9	20	the	the	DET
dhrp-28	9	21	study	study	NOUN
dhrp-28	9	22	were	be	AUX
dhrp-28	9	23	in	in	ADP
dhrp-28	9	24	vitro	vitro	X
dhrp-28	9	25	and	and	CCONJ
dhrp-28	9	26	the	the	DET
dhrp-28	9	27	trials	trial	NOUN
dhrp-28	9	28	had	have	VERB
dhrp-28	9	29	yet	yet	ADV
dhrp-28	9	30	to	to	PART
dhrp-28	9	31	be	be	AUX
dhrp-28	9	32	conducted	conduct	VERB
dhrp-28	9	33	in	in	ADP
dhrp-28	9	34	humans	human	NOUN
dhrp-28	9	35	(	(	PUNCT
dhrp-28	9	36	2	2	NUM
dhrp-28	9	37	)	)	PUNCT
dhrp-28	9	38	.	.	PUNCT
dhrp-28	10	1	despite	despite	SCONJ
dhrp-28	10	2	these	these	DET
dhrp-28	10	3	contradictory	contradictory	ADJ
dhrp-28	10	4	observations	observation	NOUN
dhrp-28	10	5	and	and	CCONJ
dhrp-28	10	6	in	in	ADP
dhrp-28	10	7	the	the	DET
dhrp-28	10	8	face	face	NOUN
dhrp-28	10	9	of	of	ADP
dhrp-28	10	10	the	the	DET
dhrp-28	10	11	lack	lack	NOUN
dhrp-28	10	12	of	of	ADP
dhrp-28	10	13	an	an	DET
dhrp-28	10	14	approved	approve	VERB
dhrp-28	10	15	drug	drug	NOUN
dhrp-28	10	16	treatment	treatment	NOUN
dhrp-28	10	17	for	for	ADP
dhrp-28	10	18	covid-19	covid-19	PROPN
dhrp-28	10	19	,	,	PUNCT
dhrp-28	10	20	many	many	ADJ
dhrp-28	10	21	patients	patient	NOUN
dhrp-28	10	22	resorted	resort	VERB
dhrp-28	10	23	to	to	ADP
dhrp-28	10	24	the	the	DET
dhrp-28	10	25	use	use	NOUN
dhrp-28	10	26	of	of	ADP
dhrp-28	10	27	ivermectin	ivermectin	NOUN
dhrp-28	10	28	for	for	ADP
dhrp-28	10	29	both	both	CCONJ
dhrp-28	10	30	the	the	DET
dhrp-28	10	31	prevention	prevention	NOUN
dhrp-28	10	32	and	and	CCONJ
dhrp-28	10	33	the	the	DET
dhrp-28	10	34	treatment	treatment	NOUN
dhrp-28	10	35	of	of	ADP
dhrp-28	10	36	infection	infection	NOUN
dhrp-28	10	37	with	with	ADP
dhrp-28	10	38	sars	sar	NOUN
dhrp-28	10	39	-	-	PUNCT
dhrp-28	10	40	cov-2	cov-2	NOUN
dhrp-28	10	41	.	.	PUNCT
dhrp-28	11	1	an	an	DET
dhrp-28	11	2	extremely	extremely	ADV
dhrp-28	11	3	controversial	controversial	ADJ
dhrp-28	11	4	manuscript	manuscript	NOUN
dhrp-28	11	5	that	that	PRON
dhrp-28	11	6	was	be	AUX
dhrp-28	11	7	initially	initially	ADV
dhrp-28	11	8	published	publish	VERB
dhrp-28	11	9	in	in	ADP
dhrp-28	11	10	january	january	PROPN
dhrp-28	11	11	2021	2021	NUM
dhrp-28	11	12	and	and	CCONJ
dhrp-28	11	13	subsequently	subsequently	ADV
dhrp-28	11	14	withdrawn	withdraw	VERB
dhrp-28	11	15	by	by	ADP
dhrp-28	11	16	the	the	DET
dhrp-28	11	17	editors	editor	NOUN
dhrp-28	11	18	of	of	ADP
dhrp-28	11	19	the	the	DET
dhrp-28	11	20	frontiers	frontier	NOUN
dhrp-28	11	21	in	in	ADP
dhrp-28	11	22	pharmacology	pharmacology	NOUN
dhrp-28	11	23	had	have	VERB
dhrp-28	11	24	undesirable	undesirable	ADJ
dhrp-28	11	25	consequences	consequence	NOUN
dhrp-28	11	26	(	(	PUNCT
dhrp-28	11	27	3	3	NUM
dhrp-28	11	28	)	)	PUNCT
dhrp-28	11	29	.	.	PUNCT
dhrp-28	12	1	the	the	DET
dhrp-28	12	2	editors	editor	NOUN
dhrp-28	12	3	concluded	conclude	VERB
dhrp-28	12	4	that	that	SCONJ
dhrp-28	12	5	this	this	DET
dhrp-28	12	6	manuscript	manuscript	NOUN
dhrp-28	12	7	contained	contain	VERB
dhrp-28	12	8	unsubstantiated	unsubstantiated	ADJ
dhrp-28	12	9	claims	claim	NOUN
dhrp-28	12	10	and	and	CCONJ
dhrp-28	12	11	violated	violate	VERB
dhrp-28	12	12	the	the	DET
dhrp-28	12	13	journal	journal	NOUN
dhrp-28	12	14	’s	’s	PART
dhrp-28	12	15	editorial	editorial	ADJ
dhrp-28	12	16	policies	policy	NOUN
dhrp-28	12	17	.	.	PUNCT
dhrp-28	13	1	unfortunately	unfortunately	ADV
dhrp-28	13	2	,	,	PUNCT
dhrp-28	13	3	despite	despite	SCONJ
dhrp-28	13	4	of	of	ADP
dhrp-28	13	5	its	its	PRON
dhrp-28	13	6	withdrawal	withdrawal	NOUN
dhrp-28	13	7	,	,	PUNCT
dhrp-28	13	8	this	this	DET
dhrp-28	13	9	manuscript	manuscript	NOUN
dhrp-28	13	10	was	be	AUX
dhrp-28	13	11	used	use	VERB
dhrp-28	13	12	by	by	ADP
dhrp-28	13	13	many	many	ADJ
dhrp-28	13	14	providers	provider	NOUN
dhrp-28	13	15	to	to	PART
dhrp-28	13	16	justify	justify	VERB
dhrp-28	13	17	the	the	DET
dhrp-28	13	18	use	use	NOUN
dhrp-28	13	19	of	of	ADP
dhrp-28	13	20	ivermectin	ivermectin	NOUN
dhrp-28	13	21	for	for	ADP
dhrp-28	13	22	the	the	DET
dhrp-28	13	23	prevention	prevention	NOUN
dhrp-28	13	24	and	and	CCONJ
dhrp-28	13	25	treatment	treatment	NOUN
dhrp-28	13	26	of	of	ADP
dhrp-28	13	27	covid-19	covid-19	PROPN
dhrp-28	13	28	.	.	PUNCT
dhrp-28	14	1	in	in	ADP
dhrp-28	14	2	an	an	DET
dhrp-28	14	3	independent	independent	ADJ
dhrp-28	14	4	review	review	NOUN
dhrp-28	14	5	of	of	ADP
dhrp-28	14	6	available	available	ADJ
dhrp-28	14	7	literature	literature	NOUN
dhrp-28	14	8	,	,	PUNCT
dhrp-28	14	9	the	the	DET
dhrp-28	14	10	author	author	NOUN
dhrp-28	14	11	’s	’s	PART
dhrp-28	14	12	concluded	conclude	VERB
dhrp-28	14	13	that	that	SCONJ
dhrp-28	14	14	“	"	PUNCT
dhrp-28	14	15	based	base	VERB
dhrp-28	14	16	on	on	ADP
dhrp-28	14	17	the	the	DET
dhrp-28	14	18	current	current	ADJ
dhrp-28	14	19	very	very	ADV
dhrp-28	14	20	low‐	low‐	PROPN
dhrp-28	14	21	to	to	ADP
dhrp-28	14	22	low‐certainty	low‐certainty	NUM
dhrp-28	14	23	evidence	evidence	NOUN
dhrp-28	14	24	,	,	PUNCT
dhrp-28	14	25	we	we	PRON
dhrp-28	14	26	are	be	AUX
dhrp-28	14	27	uncertain	uncertain	ADJ
dhrp-28	14	28	about	about	ADP
dhrp-28	14	29	the	the	DET
dhrp-28	14	30	efficacy	efficacy	NOUN
dhrp-28	14	31	and	and	CCONJ
dhrp-28	14	32	safety	safety	NOUN
dhrp-28	14	33	of	of	ADP
dhrp-28	14	34	ivermectin	ivermectin	NOUN
dhrp-28	14	35	used	use	VERB
dhrp-28	14	36	to	to	PART
dhrp-28	14	37	treat	treat	VERB
dhrp-28	14	38	or	or	CCONJ
dhrp-28	14	39	prevent	prevent	VERB
dhrp-28	14	40	covid‐19	covid‐19	PROPN
dhrp-28	14	41	.	.	PUNCT
dhrp-28	15	1	the	the	DET
dhrp-28	15	2	completed	complete	VERB
dhrp-28	15	3	studies	study	NOUN
dhrp-28	15	4	are	be	AUX
dhrp-28	15	5	small	small	ADJ
dhrp-28	15	6	,	,	PUNCT
dhrp-28	15	7	and	and	CCONJ
dhrp-28	15	8	few	few	ADJ
dhrp-28	15	9	are	be	AUX
dhrp-28	15	10	considered	consider	VERB
dhrp-28	15	11	high	high	ADJ
dhrp-28	15	12	quality	quality	NOUN
dhrp-28	15	13	.	.	PUNCT
dhrp-28	16	1	several	several	ADJ
dhrp-28	16	2	studies	study	NOUN
dhrp-28	16	3	are	be	AUX
dhrp-28	16	4	underway	underway	ADJ
dhrp-28	16	5	that	that	PRON
dhrp-28	16	6	may	may	AUX
dhrp-28	16	7	produce	produce	VERB
dhrp-28	16	8	clearer	clear	ADJ
dhrp-28	16	9	answers	answer	NOUN
dhrp-28	16	10	in	in	ADP
dhrp-28	16	11	review	review	NOUN
dhrp-28	16	12	updates	update	NOUN
dhrp-28	16	13	.	.	PUNCT
dhrp-28	17	1	overall	overall	ADV
dhrp-28	17	2	,	,	PUNCT
dhrp-28	17	3	the	the	DET
dhrp-28	17	4	reliable	reliable	ADJ
dhrp-28	17	5	evidence	evidence	NOUN
dhrp-28	17	6	available	available	ADJ
dhrp-28	17	7	does	do	AUX
dhrp-28	17	8	not	not	PART
dhrp-28	17	9	support	support	VERB
dhrp-28	17	10	the	the	DET
dhrp-28	17	11	use	use	NOUN
dhrp-28	17	12	of	of	ADP
dhrp-28	17	13	ivermectin	ivermectin	NOUN
dhrp-28	17	14	for	for	ADP
dhrp-28	17	15	treatment	treatment	NOUN
dhrp-28	17	16	or	or	CCONJ
dhrp-28	17	17	prevention	prevention	NOUN
dhrp-28	17	18	of	of	ADP
dhrp-28	17	19	covid‐19	covid‐19	PROPN
dhrp-28	17	20	outside	outside	ADP
dhrp-28	17	21	of	of	ADP
dhrp-28	17	22	well‐designed	well‐designe	VERB
dhrp-28	17	23	randomized	randomized	ADJ
dhrp-28	17	24	trials	trial	NOUN
dhrp-28	17	25	”	"	PUNCT
dhrp-28	17	26	(	(	PUNCT
dhrp-28	17	27	4	4	NUM
dhrp-28	17	28	)	)	PUNCT
dhrp-28	17	29	.	.	PUNCT
dhrp-28	18	1	regrettably	regrettably	ADV
dhrp-28	18	2	,	,	PUNCT
dhrp-28	18	3	despite	despite	SCONJ
dhrp-28	18	4	overwhelming	overwhelming	ADJ
dhrp-28	18	5	scientific	scientific	ADJ
dhrp-28	18	6	evidence	evidence	NOUN
dhrp-28	18	7	denouncing	denounce	VERB
dhrp-28	18	8	the	the	DET
dhrp-28	18	9	use	use	NOUN
dhrp-28	18	10	of	of	ADP
dhrp-28	18	11	ivermectin	ivermectin	NOUN
dhrp-28	18	12	for	for	ADP
dhrp-28	18	13	prevention	prevention	NOUN
dhrp-28	18	14	and	and	CCONJ
dhrp-28	18	15	treatment	treatment	NOUN
dhrp-28	18	16	of	of	ADP
dhrp-28	18	17	covid-19	covid-19	PROPN
dhrp-28	18	18	supported	support	VERB
dhrp-28	18	19	by	by	ADP
dhrp-28	18	20	strong	strong	ADJ
dhrp-28	18	21	fda	fda	PROPN
dhrp-28	18	22	denunciation	denunciation	NOUN
dhrp-28	18	23	,	,	PUNCT
dhrp-28	18	24	the	the	DET
dhrp-28	18	25	use	use	NOUN
dhrp-28	18	26	of	of	ADP
dhrp-28	18	27	this	this	DET
dhrp-28	18	28	drug	drug	NOUN
dhrp-28	18	29	for	for	ADP
dhrp-28	18	30	this	this	DET
dhrp-28	18	31	indication	indication	NOUN
dhrp-28	18	32	has	have	AUX
dhrp-28	18	33	not	not	PART
dhrp-28	18	34	abated	abate	VERB
dhrp-28	18	35	(	(	PUNCT
dhrp-28	18	36	5	5	NUM
dhrp-28	18	37	)	)	PUNCT
dhrp-28	18	38	.	.	PUNCT
dhrp-28	19	1	a	a	DET
dhrp-28	19	2	recent	recent	ADJ
dhrp-28	19	3	study	study	NOUN
dhrp-28	19	4	examining	examine	VERB
dhrp-28	19	5	trends	trend	NOUN
dhrp-28	19	6	in	in	ADP
dhrp-28	19	7	ivermectin	ivermectin	NOUN
dhrp-28	19	8	dispensing	dispense	VERB
dhrp-28	19	9	from	from	ADP
dhrp-28	19	10	outpatient	outpatient	NOUN
dhrp-28	19	11	retail	retail	ADJ
dhrp-28	19	12	pharmacies	pharmacy	NOUN
dhrp-28	19	13	in	in	ADP
dhrp-28	19	14	the	the	DET
dhrp-28	19	15	united	united	PROPN
dhrp-28	19	16	states	states	PROPN
dhrp-28	19	17	during	during	ADP
dhrp-28	19	18	the	the	DET
dhrp-28	19	19	covid-19	covid-19	PROPN
dhrp-28	19	20	pandemic	pandemic	NOUN
dhrp-28	19	21	showed	show	VERB
dhrp-28	19	22	an	an	DET
dhrp-28	19	23	increase	increase	NOUN
dhrp-28	19	24	from	from	ADP
dhrp-28	19	25	an	an	DET
dhrp-28	19	26	average	average	NOUN
dhrp-28	19	27	of	of	ADP
dhrp-28	19	28	3,600	3,600	NUM
dhrp-28	19	29	prescriptions	prescription	NOUN
dhrp-28	19	30	per	per	ADP
dhrp-28	19	31	week	week	NOUN
dhrp-28	19	32	at	at	ADP
dhrp-28	19	33	the	the	DET
dhrp-28	19	34	pre	pre	ADJ
dhrp-28	19	35	-	-	ADJ
dhrp-28	19	36	pandemic	pandemic	ADJ
dhrp-28	19	37	baseline	baseline	NOUN
dhrp-28	19	38	(	(	PUNCT
dhrp-28	19	39	march	march	PROPN
dhrp-28	19	40	16	16	NUM
dhrp-28	19	41	,	,	PUNCT
dhrp-28	19	42	2019	2019	NUM
dhrp-28	19	43	–	–	PUNCT
dhrp-28	19	44	march	march	PROPN
dhrp-28	19	45	13	13	NUM
dhrp-28	19	46	,	,	PUNCT
dhrp-28	19	47	2020	2020	NUM
dhrp-28	19	48	)	)	PUNCT
dhrp-28	19	49	to	to	ADP
dhrp-28	19	50	a	a	DET
dhrp-28	19	51	peak	peak	NOUN
dhrp-28	19	52	of	of	ADP
dhrp-28	19	53	39,000	39,000	NUM
dhrp-28	19	54	prescriptions	prescription	NOUN
dhrp-28	19	55	in	in	ADP
dhrp-28	19	56	the	the	DET
dhrp-28	19	57	week	week	NOUN
dhrp-28	19	58	ending	end	VERB
dhrp-28	19	59	on	on	ADP
dhrp-28	19	60	january	january	PROPN
dhrp-28	19	61	8	8	NUM
dhrp-28	19	62	,	,	PUNCT
dhrp-28	19	63	2021	2021	NUM
dhrp-28	19	64	.	.	PUNCT
dhrp-28	20	1	since	since	SCONJ
dhrp-28	20	2	early	early	ADJ
dhrp-28	20	3	july	july	PROPN
dhrp-28	20	4	2021	2021	NUM
dhrp-28	20	5	,	,	PUNCT
dhrp-28	20	6	outpatient	outpatient	NOUN
dhrp-28	20	7	ivermectin	ivermectin	NOUN
dhrp-28	20	8	dispensing	dispensing	NOUN
dhrp-28	20	9	has	have	AUX
dhrp-28	20	10	again	again	ADV
dhrp-28	20	11	begun	begin	VERB
dhrp-28	20	12	to	to	PART
dhrp-28	20	13	rapidly	rapidly	ADV
dhrp-28	20	14	increase	increase	VERB
dhrp-28	20	15	,	,	PUNCT
dhrp-28	20	16	reaching	reach	VERB
dhrp-28	20	17	more	more	ADJ
dhrp-28	20	18	than	than	ADP
dhrp-28	20	19	88,000	88,000	NUM
dhrp-28	20	20	prescriptions	prescription	NOUN
dhrp-28	20	21	in	in	ADP
dhrp-28	20	22	the	the	DET
dhrp-28	20	23	week	week	NOUN
dhrp-28	20	24	ending	end	VERB
dhrp-28	20	25	august	august	PROPN
dhrp-28	20	26	13	13	NUM
dhrp-28	20	27	,	,	PUNCT
dhrp-28	20	28	2021	2021	NUM
dhrp-28	20	29	.	.	PUNCT
dhrp-28	21	1	this	this	PRON
dhrp-28	21	2	represents	represent	VERB
dhrp-28	21	3	a	a	DET
dhrp-28	21	4	24fold	24fold	NUM
dhrp-28	21	5	increase	increase	NOUN
dhrp-28	21	6	from	from	ADP
dhrp-28	21	7	the	the	DET
dhrp-28	21	8	pre	pre	ADJ
dhrp-28	21	9	-	-	ADJ
dhrp-28	21	10	pandemic	pandemic	ADJ
dhrp-28	21	11	baseline	baseline	NOUN
dhrp-28	21	12	.	.	PUNCT
dhrp-28	22	1	(	(	PUNCT
dhrp-28	22	2	6	6	NUM
dhrp-28	22	3	)	)	PUNCT
dhrp-28	22	4	.	.	PUNCT
dhrp-28	23	1	dhrp	dhrp	ADJ
dhrp-28	23	2	,	,	PUNCT
dhrp-28	23	3	2021	2021	NUM
dhrp-28	23	4	,	,	PUNCT
dhrp-28	23	5	vol	vol	NOUN
dhrp-28	23	6	.	.	NOUN
dhrp-28	23	7	1	1	NUM
dhrp-28	23	8	(	(	PUNCT
dhrp-28	23	9	s4	s4	PROPN
dhrp-28	23	10	)	)	PUNCT
dhrp-28	23	11	17	17	NUM
dhrp-28	23	12	-	-	SYM
dhrp-28	23	13	19	19	NUM
dhrp-28	23	14	editorial	editorial	NOUN
dhrp-28	23	15	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-28	23	16	18	18	NUM
dhrp-28	23	17	©	©	PROPN
dhrp-28	23	18	dhr	dhr	PROPN
dhrp-28	23	19	health	health	PROPN
dhrp-28	23	20	institute	institute	PROPN
dhrp-28	23	21	for	for	ADP
dhrp-28	23	22	research	research	NOUN
dhrp-28	23	23	and	and	CCONJ
dhrp-28	23	24	development	development	NOUN
dhrp-28	23	25	the	the	DET
dhrp-28	23	26	recent	recent	ADJ
dhrp-28	23	27	use	use	NOUN
dhrp-28	23	28	of	of	ADP
dhrp-28	23	29	ivermectin	ivermectin	NOUN
dhrp-28	23	30	that	that	PRON
dhrp-28	23	31	has	have	AUX
dhrp-28	23	32	been	be	AUX
dhrp-28	23	33	formulated	formulate	VERB
dhrp-28	23	34	for	for	ADP
dhrp-28	23	35	veterinary	veterinary	ADJ
dhrp-28	23	36	use	use	NOUN
dhrp-28	23	37	has	have	AUX
dhrp-28	23	38	created	create	VERB
dhrp-28	23	39	additional	additional	ADJ
dhrp-28	23	40	challenges	challenge	NOUN
dhrp-28	23	41	.	.	PUNCT
dhrp-28	24	1	self	self	NOUN
dhrp-28	24	2	-	-	PUNCT
dhrp-28	24	3	administering	administering	NOUN
dhrp-28	24	4	of	of	ADP
dhrp-28	24	5	the	the	DET
dhrp-28	24	6	drug	drug	NOUN
dhrp-28	24	7	for	for	ADP
dhrp-28	24	8	sars	sar	NOUN
dhrp-28	24	9	-	-	PUNCT
dhrp-28	24	10	cov-2	cov-2	PART
dhrp-28	24	11	infections	infection	NOUN
dhrp-28	24	12	have	have	AUX
dhrp-28	24	13	led	lead	VERB
dhrp-28	24	14	to	to	ADP
dhrp-28	24	15	an	an	DET
dhrp-28	24	16	unprecedented	unprecedented	ADJ
dhrp-28	24	17	increase	increase	NOUN
dhrp-28	24	18	in	in	ADP
dhrp-28	24	19	calls	call	NOUN
dhrp-28	24	20	to	to	ADP
dhrp-28	24	21	the	the	DET
dhrp-28	24	22	texas	texas	PROPN
dhrp-28	24	23	poison	poison	PROPN
dhrp-28	24	24	center	center	NOUN
dhrp-28	24	25	network	network	NOUN
dhrp-28	24	26	.	.	PUNCT
dhrp-28	25	1	the	the	DET
dhrp-28	25	2	texas	texas	PROPN
dhrp-28	25	3	department	department	PROPN
dhrp-28	25	4	of	of	ADP
dhrp-28	25	5	state	state	PROPN
dhrp-28	25	6	health	health	NOUN
dhrp-28	25	7	services	service	NOUN
dhrp-28	25	8	has	have	AUX
dhrp-28	25	9	issued	issue	VERB
dhrp-28	25	10	a	a	DET
dhrp-28	25	11	health	health	NOUN
dhrp-28	25	12	advisory	advisory	NOUN
dhrp-28	25	13	over	over	ADP
dhrp-28	25	14	the	the	DET
dhrp-28	25	15	improper	improper	ADJ
dhrp-28	25	16	use	use	NOUN
dhrp-28	25	17	of	of	ADP
dhrp-28	25	18	ivermectin	ivermectin	NOUN
dhrp-28	25	19	to	to	PART
dhrp-28	25	20	treat	treat	VERB
dhrp-28	25	21	or	or	CCONJ
dhrp-28	25	22	prevent	prevent	VERB
dhrp-28	25	23	covid-19	covid-19	PROPN
dhrp-28	25	24	after	after	SCONJ
dhrp-28	25	25	calls	call	NOUN
dhrp-28	25	26	to	to	ADP
dhrp-28	25	27	the	the	DET
dhrp-28	25	28	texas	texas	PROPN
dhrp-28	25	29	poison	poison	PROPN
dhrp-28	25	30	center	center	NOUN
dhrp-28	25	31	network	network	NOUN
dhrp-28	25	32	for	for	ADP
dhrp-28	25	33	people	people	NOUN
dhrp-28	25	34	exposed	expose	VERB
dhrp-28	25	35	to	to	ADP
dhrp-28	25	36	the	the	DET
dhrp-28	25	37	drug	drug	NOUN
dhrp-28	25	38	increased	increase	VERB
dhrp-28	25	39	150	150	NUM
dhrp-28	25	40	%	%	NOUN
dhrp-28	25	41	(	(	PUNCT
dhrp-28	25	42	7	7	NUM
dhrp-28	25	43	)	)	PUNCT
dhrp-28	25	44	.	.	PUNCT
dhrp-28	26	1	this	this	PRON
dhrp-28	26	2	is	be	AUX
dhrp-28	26	3	a	a	DET
dhrp-28	26	4	nation	nation	NOUN
dhrp-28	26	5	-	-	PUNCT
dhrp-28	26	6	wide	wide	ADJ
dhrp-28	26	7	observation	observation	NOUN
dhrp-28	26	8	as	as	SCONJ
dhrp-28	26	9	most	most	ADJ
dhrp-28	26	10	hospitals	hospital	NOUN
dhrp-28	26	11	have	have	AUX
dhrp-28	26	12	reported	report	VERB
dhrp-28	26	13	similar	similar	ADJ
dhrp-28	26	14	toxicity	toxicity	NOUN
dhrp-28	26	15	profiles	profile	NOUN
dhrp-28	26	16	due	due	ADJ
dhrp-28	26	17	to	to	ADP
dhrp-28	26	18	iniquitous	iniquitous	ADJ
dhrp-28	26	19	use	use	NOUN
dhrp-28	26	20	of	of	ADP
dhrp-28	26	21	ivermectin	ivermectin	NOUN
dhrp-28	26	22	for	for	ADP
dhrp-28	26	23	the	the	DET
dhrp-28	26	24	prevention	prevention	NOUN
dhrp-28	26	25	and	and	CCONJ
dhrp-28	26	26	treatment	treatment	NOUN
dhrp-28	26	27	of	of	ADP
dhrp-28	26	28	covid-19	covid-19	PROPN
dhrp-28	26	29	.	.	PUNCT
dhrp-28	27	1	in	in	ADP
dhrp-28	27	2	addition	addition	NOUN
dhrp-28	27	3	to	to	ADP
dhrp-28	27	4	the	the	DET
dhrp-28	27	5	fda	fda	PROPN
dhrp-28	27	6	and	and	CCONJ
dhrp-28	27	7	the	the	DET
dhrp-28	27	8	u.s	u.s	PROPN
dhrp-28	27	9	.	.	PROPN
dhrp-28	27	10	centers	center	NOUN
dhrp-28	27	11	for	for	ADP
dhrp-28	27	12	disease	disease	NOUN
dhrp-28	27	13	control	control	NOUN
dhrp-28	27	14	and	and	CCONJ
dhrp-28	27	15	prevention	prevention	NOUN
dhrp-28	27	16	,	,	PUNCT
dhrp-28	27	17	organizations	organization	NOUN
dhrp-28	27	18	such	such	ADJ
dhrp-28	27	19	as	as	ADP
dhrp-28	27	20	american	american	PROPN
dhrp-28	27	21	medical	medical	PROPN
dhrp-28	27	22	association	association	PROPN
dhrp-28	27	23	and	and	CCONJ
dhrp-28	27	24	american	american	PROPN
dhrp-28	27	25	pharmacist	pharmacist	PROPN
dhrp-28	27	26	association	association	PROPN
dhrp-28	27	27	have	have	AUX
dhrp-28	27	28	also	also	ADV
dhrp-28	27	29	strongly	strongly	ADV
dhrp-28	27	30	opposed	oppose	VERB
dhrp-28	27	31	the	the	DET
dhrp-28	27	32	ordering	ordering	NOUN
dhrp-28	27	33	,	,	PUNCT
dhrp-28	27	34	prescribing	prescribing	NOUN
dhrp-28	27	35	,	,	PUNCT
dhrp-28	27	36	or	or	CCONJ
dhrp-28	27	37	dispensing	dispensing	NOUN
dhrp-28	27	38	of	of	ADP
dhrp-28	27	39	ivermectin	ivermectin	NOUN
dhrp-28	27	40	to	to	PART
dhrp-28	27	41	prevent	prevent	VERB
dhrp-28	27	42	or	or	CCONJ
dhrp-28	27	43	treat	treat	VERB
dhrp-28	27	44	covid-19	covid-19	PROPN
dhrp-28	27	45	outside	outside	ADP
dhrp-28	27	46	of	of	ADP
dhrp-28	27	47	a	a	DET
dhrp-28	27	48	clinical	clinical	ADJ
dhrp-28	27	49	trial	trial	NOUN
dhrp-28	27	50	(	(	PUNCT
dhrp-28	27	51	8)	8)	NUM
dhrp-28	27	52	.	.	PUNCT
dhrp-28	27	53	national	national	PROPN
dhrp-28	27	54	institutes	institutes	PROPN
dhrp-28	27	55	of	of	ADP
dhrp-28	27	56	health	health	NOUN
dhrp-28	27	57	has	have	AUX
dhrp-28	27	58	designed	design	VERB
dhrp-28	27	59	double	double	ADJ
dhrp-28	27	60	-	-	PUNCT
dhrp-28	27	61	blinded	blind	VERB
dhrp-28	27	62	randomized	randomize	VERB
dhrp-28	27	63	placebocontrol	placebocontrol	NOUN
dhrp-28	27	64	clinical	clinical	ADJ
dhrp-28	27	65	trials	trial	NOUN
dhrp-28	27	66	to	to	PART
dhrp-28	27	67	ascertain	ascertain	VERB
dhrp-28	27	68	the	the	DET
dhrp-28	27	69	safety	safety	NOUN
dhrp-28	27	70	and	and	CCONJ
dhrp-28	27	71	effectiveness	effectiveness	NOUN
dhrp-28	27	72	of	of	ADP
dhrp-28	27	73	ivermectin	ivermectin	NOUN
dhrp-28	27	74	and	and	CCONJ
dhrp-28	27	75	other	other	ADJ
dhrp-28	27	76	repurposed	repurpose	VERB
dhrp-28	27	77	drugs	drug	NOUN
dhrp-28	27	78	in	in	ADP
dhrp-28	27	79	the	the	DET
dhrp-28	27	80	prevention	prevention	NOUN
dhrp-28	27	81	and	and	CCONJ
dhrp-28	27	82	treatment	treatment	NOUN
dhrp-28	27	83	of	of	ADP
dhrp-28	27	84	covid19	covid19	NOUN
dhrp-28	27	85	.	.	PUNCT
dhrp-28	28	1	dhr	dhr	PROPN
dhrp-28	28	2	health	health	PROPN
dhrp-28	28	3	institute	institute	PROPN
dhrp-28	28	4	for	for	ADP
dhrp-28	28	5	research	research	NOUN
dhrp-28	28	6	and	and	CCONJ
dhrp-28	28	7	development	development	NOUN
dhrp-28	28	8	is	be	AUX
dhrp-28	28	9	involved	involve	VERB
dhrp-28	28	10	in	in	ADP
dhrp-28	28	11	these	these	DET
dhrp-28	28	12	studies	study	NOUN
dhrp-28	28	13	,	,	PUNCT
dhrp-28	28	14	and	and	CCONJ
dhrp-28	28	15	it	it	PRON
dhrp-28	28	16	is	be	AUX
dhrp-28	28	17	expected	expect	VERB
dhrp-28	28	18	that	that	SCONJ
dhrp-28	28	19	the	the	DET
dhrp-28	28	20	results	result	NOUN
dhrp-28	28	21	of	of	ADP
dhrp-28	28	22	these	these	DET
dhrp-28	28	23	prospective	prospective	ADJ
dhrp-28	28	24	clinical	clinical	ADJ
dhrp-28	28	25	trials	trial	NOUN
dhrp-28	28	26	would	would	AUX
dhrp-28	28	27	unequivocally	unequivocally	ADV
dhrp-28	28	28	establish	establish	VERB
dhrp-28	28	29	the	the	DET
dhrp-28	28	30	benefit	benefit	NOUN
dhrp-28	28	31	(	(	PUNCT
dhrp-28	28	32	or	or	CCONJ
dhrp-28	28	33	otherwise	otherwise	ADV
dhrp-28	28	34	)	)	PUNCT
dhrp-28	28	35	of	of	ADP
dhrp-28	28	36	these	these	DET
dhrp-28	28	37	agents	agent	NOUN
dhrp-28	28	38	.	.	PUNCT
dhrp-28	29	1	considering	consider	VERB
dhrp-28	29	2	the	the	DET
dhrp-28	29	3	available	available	ADJ
dhrp-28	29	4	scientific	scientific	ADJ
dhrp-28	29	5	evidence	evidence	NOUN
dhrp-28	29	6	,	,	PUNCT
dhrp-28	29	7	it	it	PRON
dhrp-28	29	8	is	be	AUX
dhrp-28	29	9	strongly	strongly	ADV
dhrp-28	29	10	recommended	recommend	VERB
dhrp-28	29	11	that	that	SCONJ
dhrp-28	29	12	ivermectin	ivermectin	NOUN
dhrp-28	29	13	should	should	AUX
dhrp-28	29	14	not	not	PART
dhrp-28	29	15	be	be	AUX
dhrp-28	29	16	prescribed	prescribe	VERB
dhrp-28	29	17	and/or	and/or	CCONJ
dhrp-28	29	18	self	self	NOUN
dhrp-28	29	19	-	-	PUNCT
dhrp-28	29	20	administered	administer	VERB
dhrp-28	29	21	for	for	ADP
dhrp-28	29	22	the	the	DET
dhrp-28	29	23	prevention	prevention	NOUN
dhrp-28	29	24	or	or	CCONJ
dhrp-28	29	25	treatment	treatment	NOUN
dhrp-28	29	26	of	of	ADP
dhrp-28	29	27	covid-19	covid-19	PROPN
dhrp-28	29	28	.	.	PUNCT
dhrp-28	30	1	additionally	additionally	ADV
dhrp-28	30	2	,	,	PUNCT
dhrp-28	30	3	it	it	PRON
dhrp-28	30	4	must	must	AUX
dhrp-28	30	5	be	be	AUX
dhrp-28	30	6	stressed	stress	VERB
dhrp-28	30	7	that	that	SCONJ
dhrp-28	30	8	vaccination	vaccination	NOUN
dhrp-28	30	9	remains	remain	VERB
dhrp-28	30	10	the	the	DET
dhrp-28	30	11	most	most	ADV
dhrp-28	30	12	effective	effective	ADJ
dhrp-28	30	13	approach	approach	NOUN
dhrp-28	30	14	for	for	ADP
dhrp-28	30	15	the	the	DET
dhrp-28	30	16	prevention	prevention	NOUN
dhrp-28	30	17	of	of	ADP
dhrp-28	30	18	covid-19	covid-19	PROPN
dhrp-28	30	19	and	and	CCONJ
dhrp-28	30	20	informing	inform	VERB
dhrp-28	30	21	the	the	DET
dhrp-28	30	22	public	public	NOUN
dhrp-28	30	23	about	about	ADP
dhrp-28	30	24	proper	proper	ADJ
dhrp-28	30	25	treatment	treatment	NOUN
dhrp-28	30	26	options	option	NOUN
dhrp-28	30	27	is	be	AUX
dhrp-28	30	28	the	the	DET
dhrp-28	30	29	apposite	apposite	ADJ
dhrp-28	30	30	course	course	NOUN
dhrp-28	30	31	of	of	ADP
dhrp-28	30	32	action	action	NOUN
dhrp-28	30	33	towards	towards	ADP
dhrp-28	30	34	ending	end	VERB
dhrp-28	30	35	this	this	DET
dhrp-28	30	36	global	global	ADJ
dhrp-28	30	37	pandemic	pandemic	NOUN
dhrp-28	30	38	.	.	PUNCT
dhrp-28	31	1	references	reference	NOUN
dhrp-28	31	2	1	1	NUM
dhrp-28	31	3	.	.	PUNCT
dhrp-28	32	1	zaidi	zaidi	PROPN
dhrp-28	32	2	,	,	PUNCT
dhrp-28	32	3	a.k	a.k	PROPN
dhrp-28	32	4	.	.	PROPN
dhrp-28	32	5	,	,	PUNCT
dhrp-28	32	6	dehgani	dehgani	NOUN
dhrp-28	32	7	-	-	PUNCT
dhrp-28	32	8	mobaraki	mobaraki	PROPN
dhrp-28	32	9	,	,	PUNCT
dhrp-28	32	10	p.	p.	NOUN
dhrp-28	32	11	the	the	DET
dhrp-28	32	12	mechanisms	mechanism	NOUN
dhrp-28	32	13	of	of	ADP
dhrp-28	32	14	action	action	NOUN
dhrp-28	32	15	of	of	ADP
dhrp-28	32	16	ivermectin	ivermectin	NOUN
dhrp-28	32	17	against	against	ADP
dhrp-28	32	18	sars	sar	NOUN
dhrp-28	32	19	-	-	PUNCT
dhrp-28	32	20	cov-2	cov-2	NOUN
dhrp-28	32	21	:	:	PUNCT
dhrp-28	32	22	an	an	DET
dhrp-28	32	23	evidence	evidence	NOUN
dhrp-28	32	24	-	-	PUNCT
dhrp-28	32	25	based	base	VERB
dhrp-28	32	26	clinical	clinical	ADJ
dhrp-28	32	27	review	review	NOUN
dhrp-28	32	28	article	article	NOUN
dhrp-28	32	29	.	.	PUNCT
dhrp-28	33	1	j	j	PROPN
dhrp-28	33	2	antibiot	antibiot	PROPN
dhrp-28	33	3	(	(	PUNCT
dhrp-28	33	4	2021	2021	NUM
dhrp-28	33	5	)	)	PUNCT
dhrp-28	33	6	.	.	PUNCT
dhrp-28	34	1	https://doi.org/10.1038/s41429-021-00430-5	https://doi.org/10.1038/s41429-021-00430-5	NUM
dhrp-28	35	1	2	2	X
dhrp-28	35	2	.	.	X
dhrp-28	35	3	caly	caly	PROPN
dhrp-28	35	4	,	,	PUNCT
dhrp-28	35	5	l.	l.	PROPN
dhrp-28	35	6	,	,	PUNCT
dhrp-28	35	7	druce	druce	PROPN
dhrp-28	35	8	,	,	PUNCT
dhrp-28	35	9	j.d	j.d	PROPN
dhrp-28	35	10	.	.	PROPN
dhrp-28	35	11	,	,	PUNCT
dhrp-28	35	12	et.al	et.al	PROPN
dhrp-28	35	13	.	.	PUNCT
dhrp-28	36	1	the	the	DET
dhrp-28	36	2	fda	fda	PROPN
dhrp-28	36	3	-	-	PUNCT
dhrp-28	36	4	approved	approve	VERB
dhrp-28	36	5	drug	drug	NOUN
dhrp-28	36	6	ivermectin	ivermectin	NOUN
dhrp-28	36	7	inhibits	inhibit	VERB
dhrp-28	36	8	the	the	DET
dhrp-28	36	9	replication	replication	NOUN
dhrp-28	36	10	of	of	ADP
dhrp-28	36	11	sars	sar	NOUN
dhrp-28	36	12	-	-	PUNCT
dhrp-28	36	13	cov-2	cov-2	NOUN
dhrp-28	36	14	in	in	ADP
dhrp-28	36	15	vitro	vitro	X
dhrp-28	36	16	.	.	PUNCT
dhrp-28	37	1	antiviral	antiviral	ADJ
dhrp-28	37	2	res	re	NOUN
dhrp-28	37	3	.	.	PUNCT
dhrp-28	38	1	2020	2020	NUM
dhrp-28	38	2	;	;	PUNCT
dhrp-28	38	3	178:104787	178:104787	NUM
dhrp-28	38	4	.	.	NOUN
dhrp-28	39	1	3	3	X
dhrp-28	39	2	.	.	X
dhrp-28	39	3	offord	offord	PROPN
dhrp-28	39	4	,	,	PUNCT
dhrp-28	39	5	c.	c.	PROPN
dhrp-28	39	6	frontiers	frontier	NOUN
dhrp-28	39	7	pulls	pull	VERB
dhrp-28	39	8	special	special	ADJ
dhrp-28	39	9	covid-19	covid-19	PROPN
dhrp-28	39	10	issue	issue	NOUN
dhrp-28	39	11	after	after	ADP
dhrp-28	39	12	content	content	NOUN
dhrp-28	39	13	dispute	dispute	NOUN
dhrp-28	39	14	.	.	PUNCT
dhrp-28	40	1	the	the	DET
dhrp-28	40	2	scientist	scientist	NOUN
dhrp-28	40	3	.	.	PUNCT
dhrp-28	40	4	2021	2021	NUM
dhrp-28	40	5	.	.	PUNCT
dhrp-28	41	1	https://www.thescientist.com/news-opinion/frontiers-pulls-special-covid-19issue-after-content-dispute-68721	https://www.thescientist.com/news-opinion/frontiers-pulls-special-covid-19issue-after-content-dispute-68721	PROPN
dhrp-28	41	2	4	4	NUM
dhrp-28	41	3	.	.	PUNCT
dhrp-28	42	1	popp	popp	PROPN
dhrp-28	42	2	,	,	PUNCT
dhrp-28	42	3	m.	m.	NOUN
dhrp-28	42	4	,	,	PUNCT
dhrp-28	42	5	stegemann	stegemann	PROPN
dhrp-28	42	6	,	,	PUNCT
dhrp-28	42	7	m.	m.	NOUN
dhrp-28	42	8	,	,	PUNCT
dhrp-28	42	9	et	et	NOUN
dhrp-28	42	10	.	.	PUNCT
dhrp-28	43	1	al	al	PROPN
dhrp-28	43	2	.	.	PROPN
dhrp-28	43	3	ivermectin	ivermectin	NOUN
dhrp-28	43	4	for	for	ADP
dhrp-28	43	5	preventing	prevent	VERB
dhrp-28	43	6	and	and	CCONJ
dhrp-28	43	7	treating	treat	VERB
dhrp-28	43	8	covid-19	covid-19	PROPN
dhrp-28	43	9	.	.	PUNCT
dhrp-28	44	1	cochrane	cochrane	PROPN
dhrp-28	44	2	database	database	NOUN
dhrp-28	44	3	of	of	ADP
dhrp-28	44	4	systematic	systematic	ADJ
dhrp-28	44	5	reviews	review	NOUN
dhrp-28	44	6	2021	2021	NUM
dhrp-28	44	7	,	,	PUNCT
dhrp-28	44	8	issue	issue	NOUN
dhrp-28	44	9	7	7	NUM
dhrp-28	44	10	.	.	PUNCT
dhrp-28	44	11	art	art	NOUN
dhrp-28	44	12	,	,	PUNCT
dhrp-28	44	13	no	no	INTJ
dhrp-28	44	14	:	:	PUNCT
dhrp-28	44	15	cd015017	cd015017	NOUN
dhrp-28	44	16	.	.	PUNCT
dhrp-28	45	1	do1	do1	NOUN
dhrp-28	45	2	:	:	PUNCT
dhrp-28	46	1	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858	PROPN
dhrp-28	46	2	.	.	PUNCT
dhrp-28	46	3	cd015017.pub2	cd015017.pub2	PROPN
dhrp-28	46	4	/	/	SYM
dhrp-28	46	5	full	full	ADJ
dhrp-28	46	6	5	5	NUM
dhrp-28	46	7	.	.	PUNCT
dhrp-28	47	1	why	why	SCONJ
dhrp-28	47	2	you	you	PRON
dhrp-28	47	3	should	should	AUX
dhrp-28	47	4	not	not	PART
dhrp-28	47	5	use	use	VERB
dhrp-28	47	6	ivermectin	ivermectin	NOUN
dhrp-28	47	7	to	to	PART
dhrp-28	47	8	treat	treat	VERB
dhrp-28	47	9	or	or	CCONJ
dhrp-28	47	10	prevent	prevent	VERB
dhrp-28	47	11	covid-19	covid-19	PROPN
dhrp-28	47	12	.	.	PROPN
dhrp-28	47	13	2021	2021	NUM
dhrp-28	47	14	.	.	PUNCT
dhrp-28	48	1	https://www.fda.gov/consumers/consumerupdates/why-you-should-not-use-ivermectin-treat-or-preventcovid-19	https://www.fda.gov/consumers/consumerupdates/why-you-should-not-use-ivermectin-treat-or-preventcovid-19	PROPN
dhrp-28	48	2	6	6	NUM
dhrp-28	48	3	.	.	PUNCT
dhrp-28	49	1	u.s	u.s	PROPN
dhrp-28	49	2	.	.	PROPN
dhrp-28	49	3	centers	center	NOUN
dhrp-28	49	4	for	for	ADP
dhrp-28	49	5	disease	disease	NOUN
dhrp-28	49	6	control	control	PROPN
dhrp-28	49	7	&	&	CCONJ
dhrp-28	49	8	prevention	prevention	NOUN
dhrp-28	49	9	.	.	PUNCT
dhrp-28	50	1	emergency	emergency	NOUN
dhrp-28	50	2	preparedness	preparedness	NOUN
dhrp-28	50	3	and	and	CCONJ
dhrp-28	50	4	response	response	NOUN
dhrp-28	50	5	.	.	PUNCT
dhrp-28	51	1	rapid	rapid	ADJ
dhrp-28	51	2	increase	increase	NOUN
dhrp-28	51	3	in	in	ADP
dhrp-28	51	4	ivermectin	ivermectin	NOUN
dhrp-28	51	5	prescriptions	prescription	NOUN
dhrp-28	51	6	and	and	CCONJ
dhrp-28	51	7	reports	report	NOUN
dhrp-28	51	8	of	of	ADP
dhrp-28	51	9	severe	severe	ADJ
dhrp-28	51	10	illness	illness	NOUN
dhrp-28	51	11	associated	associate	VERB
dhrp-28	51	12	with	with	ADP
dhrp-28	51	13	use	use	NOUN
dhrp-28	51	14	of	of	ADP
dhrp-28	51	15	products	product	NOUN
dhrp-28	51	16	containing	contain	VERB
dhrp-28	51	17	ivermectin	ivermectin	NOUN
dhrp-28	51	18	to	to	PART
dhrp-28	51	19	prevent	prevent	VERB
dhrp-28	51	20	or	or	CCONJ
dhrp-28	51	21	treat	treat	VERB
dhrp-28	51	22	covid19	covid19	NOUN
dhrp-28	51	23	.	.	PUNCT
dhrp-28	52	1	2021	2021	NUM
dhrp-28	52	2	.	.	PUNCT
dhrp-28	53	1	https://emergency.cdc.gov/han/2021/han00449.asp?acstracki	https://emergency.cdc.gov/han/2021/han00449.asp?acstracki	NOUN
dhrp-28	53	2	ngid	ngid	ADJ
dhrp-28	53	3	=	=	NUM
dhrp-28	53	4	uscdc_511dm64535&acstrackinglabel	uscdc_511dm64535&acstrackinglabel	NOUN
dhrp-28	53	5	=	=	SYM
dhrp-28	53	6	han%20449%20%20general%20public&deliveryname	han%20449%20%20general%20public&deliveryname	NOUN
dhrp-28	53	7	=	=	NOUN
dhrp-28	53	8	uscdc_511dm64535	uscdc_511dm64535	PROPN
dhrp-28	53	9	7	7	NUM
dhrp-28	53	10	.	.	X
dhrp-28	53	11	texas	texas	PROPN
dhrp-28	53	12	poison	poison	PROPN
dhrp-28	53	13	center	center	PROPN
dhrp-28	53	14	calls	call	VERB
dhrp-28	53	15	triple	triple	ADV
dhrp-28	53	16	for	for	ADP
dhrp-28	53	17	people	people	NOUN
dhrp-28	53	18	treating	treat	VERB
dhrp-28	53	19	covid19	covid19	NOUN
dhrp-28	53	20	with	with	ADP
dhrp-28	53	21	ivermectin	ivermectin	NOUN
dhrp-28	53	22	.	.	PUNCT
dhrp-28	54	1	2021	2021	NUM
dhrp-28	54	2	.	.	PUNCT
dhrp-28	55	1	https://www.msn.com/enus/health/medical/texas-poison-center-calls-triple-for-peopleself-treating-covid-19-with-ivermectin/ar-aanp5wz	https://www.msn.com/enus/health/medical/texas-poison-center-calls-triple-for-peopleself-treating-covid-19-with-ivermectin/ar-aanp5wz	VERB
dhrp-28	55	2	8	8	NUM
dhrp-28	55	3	.	.	PUNCT
dhrp-28	56	1	ama	ama	PROPN
dhrp-28	56	2	,	,	PUNCT
dhrp-28	56	3	apha	apha	PROPN
dhrp-28	56	4	,	,	PUNCT
dhrp-28	56	5	ashp	ashp	PROPN
dhrp-28	56	6	statement	statement	NOUN
dhrp-28	56	7	on	on	ADP
dhrp-28	56	8	ending	end	VERB
dhrp-28	56	9	use	use	NOUN
dhrp-28	56	10	of	of	ADP
dhrp-28	56	11	ivermectin	ivermectin	NOUN
dhrp-28	56	12	to	to	PART
dhrp-28	56	13	treat	treat	VERB
dhrp-28	56	14	covid-19	covid-19	PROPN
dhrp-28	56	15	.	.	PROPN
dhrp-28	56	16	2021	2021	NUM
dhrp-28	56	17	.	.	PUNCT
dhrp-28	57	1	https://www.ama-assn.org/presscenter/press-releases/ama-apha-ashp-statement-ending-useivermectin-treat-covid-19	https://www.ama-assn.org/presscenter/press-releases/ama-apha-ashp-statement-ending-useivermectin-treat-covid-19	PROPN
dhrp-28	57	2	sohail	sohail	PROPN
dhrp-28	57	3	rao	rao	PROPN
dhrp-28	57	4	,	,	PUNCT
dhrp-28	57	5	md	md	PROPN
dhrp-28	57	6	,	,	PUNCT
dhrp-28	57	7	ma	ma	PROPN
dhrp-28	57	8	,	,	PUNCT
dhrp-28	57	9	dphil	dphil	ADJ
dhrp-28	57	10	executive	executive	ADJ
dhrp-28	57	11	vice	vice	NOUN
dhrp-28	57	12	president	president	NOUN
dhrp-28	57	13	,	,	PUNCT
dhrp-28	57	14	dhr	dhr	PROPN
dhrp-28	57	15	health	health	PROPN
dhrp-28	57	16	,	,	PUNCT
dhrp-28	57	17	5501	5501	NUM
dhrp-28	57	18	s.	s.	PROPN
dhrp-28	57	19	mccoll	mccoll	PROPN
dhrp-28	57	20	road	road	PROPN
dhrp-28	57	21	,	,	PUNCT
dhrp-28	57	22	edinburg	edinburg	PROPN
dhrp-28	57	23	,	,	PUNCT
dhrp-28	57	24	texas	texas	PROPN
dhrp-28	57	25	president	president	PROPN
dhrp-28	57	26	&	&	CCONJ
dhrp-28	57	27	chief	chief	ADJ
dhrp-28	57	28	executive	executive	ADJ
dhrp-28	57	29	officer	officer	NOUN
dhrp-28	57	30	,	,	PUNCT
dhrp-28	57	31	dhr	dhr	PROPN
dhrp-28	57	32	health	health	PROPN
dhrp-28	57	33	institute	institute	PROPN
dhrp-28	57	34	for	for	ADP
dhrp-28	57	35	research	research	PROPN
dhrp-28	57	36	&	&	CCONJ
dhrp-28	57	37	development	development	PROPN
dhrp-28	57	38	,	,	PUNCT
dhrp-28	57	39	5323	5323	NUM
dhrp-28	57	40	s.	s.	PROPN
dhrp-28	57	41	mccoll	mccoll	PROPN
dhrp-28	57	42	road	road	PROPN
dhrp-28	57	43	,	,	PUNCT
dhrp-28	57	44	edinburg	edinburg	PROPN
dhrp-28	57	45	,	,	PUNCT
dhrp-28	57	46	texas	texas	PROPN
dhrp-28	57	47	corresponding	corresponding	PROPN
dhrp-28	57	48	author	author	NOUN
dhrp-28	57	49	email	email	NOUN
dhrp-28	57	50	:	:	PUNCT
dhrp-28	57	51	s.rao@dhr-rgv.com	s.rao@dhr-rgv.com	X
dhrp-28	57	52	disclosures	disclosure	NOUN
dhrp-28	57	53	:	:	PUNCT
dhrp-28	57	54	none	none	NOUN
dhrp-28	57	55	orcid	orcid	NOUN
dhrp-28	57	56	:	:	PUNCT
dhrp-28	57	57	sohail	sohail	PROPN
dhrp-28	57	58	rao	rao	PROPN
dhrp-28	57	59	:	:	PUNCT
dhrp-28	57	60	https://orcid.org/0000-0001-50279992	https://orcid.org/0000-0001-50279992	PROPN
dhrp-28	57	61	alec	alec	PROPN
dhrp-28	57	62	vasquez	vasquez	PROPN
dhrp-28	57	63	-	-	PUNCT
dhrp-28	57	64	kanhere	kanhere	PROPN
dhrp-28	57	65	dhr	dhr	PROPN
dhrp-28	57	66	health	health	PROPN
dhrp-28	57	67	institute	institute	PROPN
dhrp-28	57	68	for	for	ADP
dhrp-28	57	69	research	research	PROPN
dhrp-28	57	70	&	&	CCONJ
dhrp-28	57	71	development	development	PROPN
dhrp-28	57	72	,	,	PUNCT
dhrp-28	57	73	5323	5323	NUM
dhrp-28	57	74	s.	s.	PROPN
dhrp-28	57	75	mccoll	mccoll	PROPN
dhrp-28	57	76	road	road	PROPN
dhrp-28	57	77	,	,	PUNCT
dhrp-28	57	78	edinburg	edinburg	PROPN
dhrp-28	57	79	,	,	PUNCT
dhrp-28	57	80	texas	texas	PROPN
dhrp-28	57	81	disclosures	disclosure	NOUN
dhrp-28	57	82	:	:	PUNCT
dhrp-28	57	83	none	none	NOUN
dhrp-28	57	84	orcid	orcid	NOUN
dhrp-28	57	85	:	:	PUNCT
dhrp-28	57	86	alec	alec	PROPN
dhrp-28	57	87	vasquez	vasquez	PROPN
dhrp-28	57	88	-	-	PUNCT
dhrp-28	57	89	kanhere	kanhere	PROPN
dhrp-28	57	90	:	:	PUNCT
dhrp-28	57	91	https://orcid.org/0000-0002-2566-1724	https://orcid.org/0000-0002-2566-1724	PROPN
dhrp-28	57	92	https://doi.org/10.1038/s41429-021-00430-5	https://doi.org/10.1038/s41429-021-00430-5	NUM
dhrp-28	57	93	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	PROPN
dhrp-28	57	94	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	PROPN
dhrp-28	57	95	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	https://www.the-scientist.com/news-opinion/frontiers-pulls-special-covid-19-issue-after-content-dispute-68721	PROPN
dhrp-28	57	96	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd015017.pub2/full	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd015017.pub2/full	PROPN
dhrp-28	57	97	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd015017.pub2/full	https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.cd015017.pub2/full	PROPN
dhrp-28	57	98	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	PROPN
dhrp-28	57	99	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	PROPN
dhrp-28	58	1	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19	PROPN
dhrp-28	58	2	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	PROPN
dhrp-28	58	3	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	PROPN
dhrp-28	58	4	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	PROPN
dhrp-28	58	5	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	PROPN
dhrp-28	58	6	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	https://emergency.cdc.gov/han/2021/han00449.asp?acstrackingid=uscdc_511-dm64535&acstrackinglabel=han%20449%20-%20general%20public&deliveryname=uscdc_511-dm64535	PROPN
dhrp-28	58	7	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	VERB
dhrp-28	58	8	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	NOUN
dhrp-28	58	9	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	https://www.msn.com/en-us/health/medical/texas-poison-center-calls-triple-for-people-self-treating-covid-19-with-ivermectin/ar-aanp5wz	NOUN
dhrp-28	58	10	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	PROPN
dhrp-28	58	11	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	PROPN
dhrp-28	58	12	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	https://www.ama-assn.org/press-center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19	PROPN
dhrp-28	58	13	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-28	58	14	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-28	58	15	https://orcid.org/0000-0002-2566-1724	https://orcid.org/0000-0002-2566-1724	PROPN
dhrp-28	58	16	dhrp	dhrp	ADJ
dhrp-28	58	17	,	,	PUNCT
dhrp-28	58	18	2021	2021	NUM
dhrp-28	58	19	,	,	PUNCT
dhrp-28	58	20	vol	vol	NOUN
dhrp-28	58	21	.	.	NOUN
dhrp-28	58	22	1	1	NUM
dhrp-28	58	23	(	(	PUNCT
dhrp-28	58	24	s4	s4	PROPN
dhrp-28	58	25	)	)	PUNCT
dhrp-28	58	26	17	17	NUM
dhrp-28	58	27	-	-	SYM
dhrp-28	58	28	19	19	NUM
dhrp-28	58	29	editorial	editorial	NOUN
dhrp-28	58	30	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-28	58	31	19	19	NUM
dhrp-28	58	32	©	©	PROPN
dhrp-28	58	33	dhr	dhr	PROPN
dhrp-28	58	34	health	health	PROPN
dhrp-28	58	35	institute	institute	PROPN
dhrp-28	58	36	for	for	ADP
dhrp-28	58	37	research	research	NOUN
dhrp-28	58	38	and	and	CCONJ
dhrp-28	58	39	development	development	PROPN
dhrp-28	58	40	manish	manish	PROPN
dhrp-28	58	41	singh	singh	PROPN
dhrp-28	58	42	,	,	PUNCT
dhrp-28	58	43	md	md	PROPN
dhrp-28	58	44	,	,	PUNCT
dhrp-28	58	45	facs	facs	PROPN
dhrp-28	58	46	chief	chief	ADJ
dhrp-28	58	47	executive	executive	ADJ
dhrp-28	58	48	officer	officer	NOUN
dhrp-28	58	49	,	,	PUNCT
dhrp-28	58	50	dhr	dhr	PROPN
dhrp-28	58	51	health	health	PROPN
dhrp-28	58	52	,	,	PUNCT
dhrp-28	58	53	5501	5501	NUM
dhrp-28	58	54	s.	s.	PROPN
dhrp-28	58	55	mccoll	mccoll	PROPN
dhrp-28	58	56	road	road	PROPN
dhrp-28	58	57	,	,	PUNCT
dhrp-28	58	58	edinburg	edinburg	PROPN
dhrp-28	58	59	,	,	PUNCT
dhrp-28	58	60	texas	texas	PROPN
dhrp-28	58	61	disclosures	disclosure	NOUN
dhrp-28	58	62	:	:	PUNCT
dhrp-28	58	63	none	none	NOUN
dhrp-28	58	64	orcid	orcid	NOUN
dhrp-28	58	65	:	:	PUNCT
dhrp-28	59	1	manish	manish	PROPN
dhrp-28	59	2	singh	singh	PROPN
dhrp-28	59	3	:	:	PUNCT
dhrp-28	59	4	https://orcid.org/0000-00034146-3282	https://orcid.org/0000-00034146-3282	PROPN
dhrp-28	59	5	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-28	59	6	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN